Telomir Pharmaceuticals, Inc. (TELO)

CIK 1971532 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Telomir Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 19, 2026DEFA14A0001493152-26-039116
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097283
Aug 13, 202610-Q0001493152-26-037854
Aug 10, 20268-K0001493152-26-036742
Jul 28, 2026DEF 14A0001493152-26-035026
Jul 27, 202640001493152-26-034812
Jul 27, 202640001493152-26-034811
Jul 27, 202640001493152-26-034813
Jun 15, 20268-K0001493152-26-028614
Jun 9, 202630001493152-26-027958
Jun 8, 20268-K0001493152-26-027752
May 22, 202640001493152-26-025115
May 22, 202640001493152-26-025113
May 22, 202640001493152-26-025116
May 22, 202640001493152-26-025114
May 20, 20268-K0001493152-26-024517
May 14, 202610-Q0001493152-26-023010
Apr 30, 20268-K0001493152-26-019773
Apr 24, 202640001493152-26-018911
Apr 24, 20268-K0001493152-26-018867
Mar 31, 20268-K0001493152-26-013785
Mar 31, 20268-K0001493152-26-013872
Mar 27, 20268-K0001493152-26-013240
Mar 17, 202610-K0001493152-26-010625
Feb 19, 2026DEFA14A0001493152-26-007485